Glenview Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $24.4M | Buy |
4,587,407
+687,857
| +18% | +$3.65M | 0.68% | 28 |
|
2025
Q1 | $34.6M | Sell |
3,899,550
-257,774
| -6% | -$2.29M | 0.85% | 24 |
|
2024
Q4 | $57M | Buy |
4,157,324
+2,895,794
| +230% | +$39.7M | 1.44% | 23 |
|
2024
Q3 | $34.6M | Sell |
1,261,530
-2,486,902
| -66% | -$68.1M | 0.67% | 27 |
|
2024
Q2 | $91.7M | Sell |
3,748,432
-1,195,163
| -24% | -$29.2M | 1.8% | 15 |
|
2024
Q1 | $105M | Sell |
4,943,595
-340,387
| -6% | -$7.26M | 1.84% | 15 |
|
2023
Q4 | $101M | Buy |
5,283,982
+1,500,000
| +40% | +$28.7M | 2.16% | 14 |
|
2023
Q3 | $60.7M | Buy |
3,783,982
+39,094
| +1% | +$627K | 1.37% | 23 |
|
2023
Q2 | $86.8M | Sell |
3,744,888
-450,224
| -11% | -$10.4M | 1.96% | 14 |
|
2023
Q1 | $97.5M | Buy |
4,195,112
+1,097,344
| +35% | +$25.5M | 2.14% | 16 |
|
2022
Q4 | $44.9M | Buy |
3,097,768
+1,636,284
| +112% | +$23.7M | 1% | 25 |
|
2022
Q3 | $27.9M | Sell |
1,461,484
-235,307
| -14% | -$4.49M | 0.7% | 33 |
|
2022
Q2 | $30.8M | Sell |
1,696,791
-40,218
| -2% | -$731K | 0.77% | 29 |
|
2022
Q1 | $43.8M | Buy |
1,737,009
+57,262
| +3% | +$1.44M | 0.89% | 31 |
|
2021
Q4 | $46.4M | Sell |
1,679,747
-555,421
| -25% | -$15.3M | 0.99% | 32 |
|
2021
Q3 | $72.2M | Sell |
2,235,168
-240,912
| -10% | -$7.78M | 1.31% | 24 |
|
2021
Q2 | $75.7M | Sell |
2,476,080
-93,353
| -4% | -$2.85M | 1.25% | 28 |
|
2021
Q1 | $78.2M | Sell |
2,569,433
-1,113,258
| -30% | -$33.9M | 1.33% | 21 |
|
2020
Q4 | $72.8M | Buy |
3,682,691
+924,698
| +34% | +$18.3M | 1.67% | 17 |
|
2020
Q3 | $36M | Buy |
2,757,993
+947,266
| +52% | +$12.4M | 1.13% | 21 |
|
2020
Q2 | $20.5M | Buy |
1,810,727
+271,196
| +18% | +$3.08M | 0.57% | 34 |
|
2020
Q1 | $22M | Sell |
1,539,531
-1,905,264
| -55% | -$27.3M | 0.6% | 34 |
|
2019
Q4 | $93.8M | Sell |
3,444,795
-238,511
| -6% | -$6.49M | 0.82% | 31 |
|
2019
Q3 | $105M | Buy |
+3,683,306
| New | +$105M | 1.11% | 33 |
|